2022-04-01
Announcement on Acceptance of Application For Sevelamer Carbonate Powder for Oral Suspension
Shenzhen Beimei Pharmaceutical Co., LTD. (hereinafter referred to as "Beimei Pharmaceutical") has officially received the acceptance letter issued by the Drug Evaluation Center of the National Medical Products Administration.The sevelamercarbonate powder for oral suspension, which isimportedby Beimei Pharmaceutical,its application was accepted.In March 2022, Beimei ...
More +